InsiderClue
Insiders · Profile

Booth Bruce

Director at Kymera Therapeutics · Director at Sionna Therapeutics · Director at Dianthus Therapeutics, Inc. /DE/ · and 3 more. Filing since 13 Feb 2018. CIK 0001451612

KYMR Kymera Therapeutics, Inc. Director · 37 trades SION Sionna Therapeutics, Inc. Director · 14 trades DNTH Dianthus Therapeutics, Inc. /DE/ Director · 2 trades TECX Tectonic Therapeutic, Inc. Director · 1 trade COGT Cogent Biosciences, Inc. Director · 1 trade VRDN Viridian Therapeutics, Inc.\DE Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR Kymera Therapeutics, Inc.
29 Jun 2026
Director
Sold on a plan
76,650
$8.28M
14.2%
KYMR Kymera Therapeutics, Inc.
26 Jun 2026
Director
Sold on a plan
467,878
$51.60M
49.8%
KYMR Kymera Therapeutics, Inc.
25 Jun 2026
Director
Sold on a plan
548,321
$65.12M
50.9%
KYMR Kymera Therapeutics, Inc.
24 Jun 2026
Director
Sold on a plan
134,720
$13.54M
18.4%
KYMR Kymera Therapeutics, Inc.
23 Jun 2026
Director
Sold on a plan
1,408
$140.77K
0.2%
KYMR Kymera Therapeutics, Inc.
22 Jun 2026
Director
Sold on a plan
278,128
$27.57M
31.2%
KYMR Kymera Therapeutics, Inc.
18 Jun 2026
Director
Sold on a plan
115,056
$10.47M
15.1%
KYMR Kymera Therapeutics, Inc.
17 Jun 2026
Director
Sold on a plan
105,071
$9.50M
13.7%
KYMR Kymera Therapeutics, Inc.
17 Jun 2026
Director
Sold on a plan
11,741
$1.06M
100%
KYMR Kymera Therapeutics, Inc.
22 Apr 2026
Director
Sold on a plan
5,900
$530.76K
100%
KYMR Kymera Therapeutics, Inc.
22 Apr 2026
Director
Sold on a plan
100
$9.01K
0.0%
KYMR Kymera Therapeutics, Inc.
15 Apr 2026
Director
Sold on a plan
3,135
$282.46K
0.5%
KYMR Kymera Therapeutics, Inc.
15 Apr 2026
Director
Sold on a plan
2,200
$197.89K
100%
KYMR Kymera Therapeutics, Inc.
14 Apr 2026
Director
Sold on a plan
4,159
$374.19K
100%
KYMR Kymera Therapeutics, Inc.
2 Mar 2026
Director
Sold on a plan
81,866
$7.38M
10.8%
KYMR Kymera Therapeutics, Inc.
12 Dec 2025
Director
Sold at will
678
$61.73K
0.1%
KYMR Kymera Therapeutics, Inc.
11 Dec 2025
Director
Sold at will
6,101
$556.59K
0.9%
KYMR Kymera Therapeutics, Inc.
10 Dec 2025
Director
Sold at will
229,809
$21.08M
25.1%
SION Sionna Therapeutics, Inc.
21 Oct 2025
Director
Sold on a plan
88,878
$3.04M
11.5%
SION Sionna Therapeutics, Inc.
20 Oct 2025
Director
Sold on a plan
55,985
$1.80M
7.4%
SION Sionna Therapeutics, Inc.
17 Oct 2025
Director
Sold on a plan
61,124
$1.98M
7.9%
SION Sionna Therapeutics, Inc.
16 Oct 2025
Director
Sold on a plan
169,260
$5.48M
19.0%
SION Sionna Therapeutics, Inc.
15 Oct 2025
Director
Sold on a plan
115,856
$3.55M
13.4%
SION Sionna Therapeutics, Inc.
14 Oct 2025
Director
Sold on a plan
606
$18.15K
0.1%
SION Sionna Therapeutics, Inc.
13 Oct 2025
Director
Sold on a plan
58,232
$1.77M
7.0%
SION Sionna Therapeutics, Inc.
10 Oct 2025
Director
Sold on a plan
20,238
$606.74K
2.5%
SION Sionna Therapeutics, Inc.
6 Oct 2025
Director
Sold on a plan
11,800
$353.41K
1.5%
SION Sionna Therapeutics, Inc.
3 Oct 2025
Director
Sold on a plan
37,746
$1.13M
4.6%
SION Sionna Therapeutics, Inc.
1 Oct 2025
Director
Sold on a plan
200
$5.99K
0.0%
SION Sionna Therapeutics, Inc.
30 Sep 2025
Director
Sold on a plan
12,388
$372.38K
1.5%
SION Sionna Therapeutics, Inc.
29 Sep 2025
Director
Sold on a plan
66,105
$1.99M
7.7%
SION Sionna Therapeutics, Inc.
10 Feb 2025
Director
Bought
60,000
$1.08M
8.0%
KYMR Kymera Therapeutics, Inc.
9 Jul 2024
Director
Sold on a plan
453,960
$17.35M
38.6%
KYMR Kymera Therapeutics, Inc.
13 Jun 2024
Director
Sold on a plan
10,200
$356.80K
1.3%
KYMR Kymera Therapeutics, Inc.
12 Jun 2024
Director
Sold on a plan
16,740
$593.38K
2.0%
KYMR Kymera Therapeutics, Inc.
15 Mar 2024
Director
Sold on a plan
71,764
$2.90M
8.2%
KYMR Kymera Therapeutics, Inc.
14 Mar 2024
Director
Sold on a plan
55,779
$2.23M
6.4%
KYMR Kymera Therapeutics, Inc.
13 Mar 2024
Director
Sold on a plan
139,255
$5.88M
14.4%
KYMR Kymera Therapeutics, Inc.
12 Mar 2024
Director
Sold on a plan
162,918
$6.84M
16.0%
KYMR Kymera Therapeutics, Inc.
11 Mar 2024
Director
Sold on a plan
51,184
$2.19M
5.5%
KYMR Kymera Therapeutics, Inc.
12 Jan 2023
Director
Sold, plan not stated
98,720
$2.99M
10.0%
KYMR Kymera Therapeutics, Inc.
11 Jan 2023
Director
Sold, plan not stated
27,754
$831.51K
3.0%
KYMR Kymera Therapeutics, Inc.
15 Dec 2022
Director
Sold, plan not stated
3,278
$98.34K
0.4%
KYMR Kymera Therapeutics, Inc.
14 Dec 2022
Director
Sold, plan not stated
378,966
$11.89M
29.2%
KYMR Kymera Therapeutics, Inc.
3 Nov 2022
Director
Sold, plan not stated
96,397
$2.89M
8.8%
KYMR Kymera Therapeutics, Inc.
2 Nov 2022
Director
Sold, plan not stated
123,619
$3.71M
10.8%
KYMR Kymera Therapeutics, Inc.
1 Nov 2022
Director
Sold, plan not stated
77,030
$2.36M
6.8%
KYMR Kymera Therapeutics, Inc.
31 Oct 2022
Director
Sold, plan not stated
120,622
$3.65M
10.2%
KYMR Kymera Therapeutics, Inc.
28 Oct 2022
Director
Sold, plan not stated
91,050
$2.73M
7.7%
KYMR Kymera Therapeutics, Inc.
11 Aug 2021
Director
Sold, plan not stated
242,133
$14.77M
100%
KYMR Kymera Therapeutics, Inc.
12 Mar 2021
Director
Sold, plan not stated
229,350
$12.96M
100%
DNTH Dianthus Therapeutics, Inc. /DE/
29 Jun 2020
Director
Bought
1,250,000
$10.00M
opened
TECX Tectonic Therapeutic, Inc.
19 Jul 2019
Director
Bought
810,811
$15.00M
17.0%
DNTH Dianthus Therapeutics, Inc. /DE/
20 Mar 2019
Director
Sold, plan not stated
14,245
$254.42K
100%
COGT Cogent Biosciences, Inc.
3 Apr 2018
Director
Bought
94,052
$1.13M
2.9%
VRDN Viridian Therapeutics, Inc.\DE
13 Feb 2018
Director
Bought
545,454
$3.00M
67.7%
56 decisions on file.